|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | GUN35901 | Storage (From the date of receipt) |
3 years -20°C powder | |||
| 化学式 | C25H19FN2O4S |
||||||
| 分子量 | 462.49 | CAS No. | 2249435-90-1 | ||||
| Solubility (25°C)* | 体外 | DMSO | 93 mg/mL (201.08 mM) | ||||
| Ethanol | 6 mg/mL (12.97 mM) | ||||||
| Water | Insoluble | ||||||
| 体内 (毎回新しく調製した物を用意してください) |
|
||||||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||||||
| 製品説明 | SN-011 is a STING-specific antagonist with IC50 of 76 nM. |
|---|---|
| in vitro | SN-011 substantially suppresses 2′3′-cGAMP-induced STING oligomerization and phosphorylation assessed by immunoblot in HFFs. This compound specifically inhibits STING activation and STING-dependent signaling.[1] |
| in vivo | Serum antinuclear antibody is markedly reduced by SN-011 treatment. This compound also significantly reduces the number of activated CD69+ CD8 T cells and memory CD44high CD62Llow CD4 and CD8 T cells to near normal levels in the spleens of treated Trex1−/− mice. It strongly reduces inflammation and protects Trex1−/− mice from death.[1] |
| 細胞アッセイ | 細胞株 | HFFs |
|---|---|---|
| 濃度 | 1 μM - 10 μM | |
| 反応時間 | 24 h | |
| 実験の流れ | HFFs are harvested and lysed in lysis buffer with brief sonication. Cell lysate is collected and incubated with biotin (5 μM). For purified recombinant STING-CTD protein, 0.05 mg protein in 400 μL buffer (25 mM Tris-HCl, pH 7.5, 150 mM NaCl) was incubated with biotin (5 μM) for 1 h at 4 °C. Then the protein of interest was pull-down by streptavidinconjugated agarose and detected by immunoblot analysis. |
|
| 動物実験 | 動物モデル | Trex1−/− mice |
| 投薬量 | 5 mg/kg, 10 mg/kg | |
| 投与方法 | i.p. |
|
| Oral Lipid-Based Nanomedicine for the Inhibition of the cGAS-STING Pathway in Inflammatory Bowel Disease Treatment [ Mol Pharm, 2025, 10.1021/acs.molpharmaceut.4c01297] | PubMed: 40032274 |
| YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment [ Mol Cancer, 2024, 23(1):186] | PubMed: 39237909 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。